Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/26/2014US8815896 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
08/26/2014US8815895 Mediators of hedgehog signaling pathways, compositions and uses related hereto
08/26/2014US8815894 Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
08/26/2014US8815893 Hetarylaminonaphthyridines
08/26/2014US8815892 P2X7R antagonists and their use
08/26/2014US8815891 Tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
08/26/2014US8815890 Rhinitis treatment regimens
08/26/2014US8815889 Compositions and methods for increasing insulin sensitivity
08/26/2014US8815888 Forms of rifaximin and uses thereof
08/26/2014US8815887 Prophylactic or therapeutic method for Sjogren's syndrome
08/26/2014US8815886 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
08/26/2014US8815885 Methods and compositions for modulating IRE1, SRC, and ABL activity
08/26/2014US8815884 Prolyl hydroxylase inhibitors
08/26/2014US8815883 Compounds and methods for inhibiting serotonin synthesis
08/26/2014US8815882 Pyrazole aminopyrimidine derivatives as LRRK2 modulators
08/26/2014US8815881 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
08/26/2014US8815880 Crystal of tricyclic pyrazolopyrimidine derivative
08/26/2014US8815879 Substituted 4-(selenophen-2(or-3)-ylamino)pyrimidine compounds and methods of use thereof
08/26/2014US8815878 Spiro hemiaminals for treating viral diseases
08/26/2014US8815877 Serine/threonine kinase inhibitors
08/26/2014US8815876 Bicyclic heterocycle derivatives and methods of use thereof
08/26/2014US8815875 Inhibitors of fatty acid binding protein (FABP)
08/26/2014US8815874 Pyrazolopyrimidine derivative
08/26/2014US8815873 Heterocyclic amides as rock inhibitors
08/26/2014US8815872 Macrocyclics pyrimidines as aurora kinase inhibitors
08/26/2014US8815871 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
08/26/2014US8815870 4-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereof
08/26/2014US8815869 Lactam acetamides as calcium channel blockers
08/26/2014US8815868 Substituted oxindole derivatives and their use as vasopressin receptor ligands
08/26/2014US8815867 Inhibitors of c-fms kinase
08/26/2014US8815866 Aminopyridine kinase inhibitors
08/26/2014US8815865 Substituted 4-hydroxypyrimidine-5-carboxamides
08/26/2014US8815864 Indanyloxydihydrobenzofuranylacetic acids
08/26/2014US8815863 Compounds and therapeutic use thereof for protein kinase inhibition
08/26/2014US8815861 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
08/26/2014US8815860 Methods for preventing oxidative stress injury of a tissue by a Folate-TEMPOL conjugate
08/26/2014US8815859 Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereof
08/26/2014US8815858 Heterocyclic flaviviridae virus inhibitors
08/26/2014US8815857 Soluble guanylate cyclase activators
08/26/2014US8815856 Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
08/26/2014US8815855 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
08/26/2014US8815854 Substituted imidazopyridinyl compounds
08/26/2014US8815853 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
08/26/2014US8815851 Aminodihydrothiazine derivatives
08/26/2014US8815849 Hetero-bicyclic derivatives as HCV inhibitors
08/26/2014US8815848 Compositions and methods for inhibition of the JAK pathway
08/26/2014US8815847 [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
08/26/2014US8815846 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide
08/26/2014US8815845 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
08/26/2014US8815844 Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
08/26/2014US8815843 Compounds and methods of treating diabetes
08/26/2014US8815842 Anti-foot-and-mouth disease virus agent for animal belonging to family Suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family Suidae or sheep
08/26/2014US8815841 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
08/26/2014US8815840 Carbazole and carboline kinase inhibitors
08/26/2014US8815839 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
08/26/2014US8815838 Aerosol fluoroquinolone formulations for improved pharmacokinetics
08/26/2014US8815836 Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
08/26/2014US8815834 Use of dendrimers to stimulate cell growth
08/26/2014US8815833 Stable amifostine liquid concentrate
08/26/2014US8815832 Oxidized regenerated cellulose hemostatic powders and methods of making
08/26/2014US8815831 Treatment of Acinetobacter with alginate oligomers and antibiotics
08/26/2014US8815830 Nucleosides with antiviral and anticancer activity
08/26/2014US8815829 3′-azido purine nucleotide prodrugs for treatment of viral infections
08/26/2014US8815828 Therapeutic combinations for use in neoplasia
08/26/2014US8815827 Myeloid differentiation inducing agents
08/26/2014US8815821 Double-stranded oligonucleotides
08/26/2014US8815819 Anti-connexin compounds targeted to connexins and methods of use thereof
08/26/2014US8815816 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
08/26/2014US8815815 Methods for producing phytoextracts from vegetation waters and olive oil pomaces and compositions obtained thereby
08/26/2014US8815592 Methods and compositions related to dopaminergic neuronal cells
08/26/2014US8815570 Microalgae extract containing omega 3-polyunsaturated fatty acids and method for extracting oil from micro-organisms
08/26/2014US8815522 Decoy influenza therapies
08/26/2014US8815501 Flavivirus NS1 subunit vaccine
08/26/2014US8815310 Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health
08/26/2014US8815306 Methods and compositions for promoting bone and joint health
08/26/2014US8815301 Stable iron oligosaccharide compound
08/26/2014US8815300 Composition and methods for relief of neuropathological pain
08/26/2014US8815299 Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds
08/26/2014US8815294 Pharmaceutical compositions of dextran polymer derivatives and a carrier material
08/26/2014US8815293 Organic compounds
08/26/2014US8815292 Compositions and methods for treating insulin resistance and diabetes mellitus
08/26/2014US8815289 Tamper resistant dosage forms
08/26/2014US8815287 Opiod agonist formulations with releasable and sequestered antagonist
08/26/2014US8815286 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
08/26/2014US8815285 Extended release dosage forms of metoprolol
08/26/2014US8815284 Bioerodible sustained release drug delivery systems
08/26/2014US8815280 Nutritional intervention for improving muscular function and strength
08/26/2014US8815275 Coatings for medical devices comprising a therapeutic agent and a metallic material
08/26/2014US8815270 Methods and compositions for treating ectoparasite infestation
08/26/2014US8815268 Oat extracts: refining, compositions and methods of use
08/26/2014US8815262 Pharmaceutical composition and preparation for oral administration
08/26/2014US8815261 Composition for external application comprising aripiprazole and organic acid as active ingredients
08/26/2014US8815259 Drug eluting superhydrophobic coatings
08/26/2014US8815253 Compositions for inducing immune responses
08/26/2014US8815241 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
08/26/2014US8815228 Alloplastic injectable dermal filler and methods of use thereof
08/26/2014US8815227 Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
08/26/2014US8815226 Protein-polymer-drug conjugates
08/26/2014US8815220 Sunscreen comprising a curcuma extract
08/26/2014US8814837 Simple device for treating tinea unguium
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 7860